Education
About Us
Working with TipRanks
Follow Us
TBG - ETF AI Analysis
Top Page
TBG Dividend Focus ETF (TBG)
Rating:68Neutral
Price Target:
$36.00
Positive Factors
Strong Top Holdings
Several key holdings, such as Johnson & Johnson, Gilead Sciences, and Cisco Systems, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Sector Diversification
The ETF is spread across 11 sectors, including Health Care, Consumer Defensive, and Energy, reducing reliance on any single industry.
Dividend Focus
The fund emphasizes dividend-paying companies, which can provide steady income and stability during market volatility.
Negative Factors
High Geographic Concentration
With over 95% of its holdings in U.S. companies, the ETF lacks significant exposure to international markets, limiting global diversification.
Mixed Holding Performance
Some top holdings, such as Merck and Blackstone Group, have underperformed year-to-date, potentially dragging on overall returns.
Above-Average Expense Ratio
The ETF’s expense ratio is higher than many similar funds, which could reduce long-term returns for investors.
TBG vs. SPDR S&P 500 ETF (SPY)
AUM191.49M
RegionNorth America
Expense Ratio0.59%
Beta0.59
IssuerMadison Avenue
Inception DateNov 06, 2023
Dividend Yield2.53%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume61,425
30 Day Avg. Volume49,532
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
36.91Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering38
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TBG Summary
The TBG Dividend Focus ETF is designed for investors who want steady income through high dividend-paying stocks. It includes companies from various sectors, such as healthcare, energy, and technology, with top holdings like Merck & Company and Chevron. This ETF focuses on businesses with a strong history of paying and growing dividends, making it a good choice for those seeking income and long-term growth. However, new investors should be aware that the ETF’s performance can fluctuate with the overall stock market, and its focus on dividends may limit exposure to high-growth companies.
How much will it cost me?The TBG Dividend Focus ETF has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting high dividend-paying stocks across various sectors to maximize income and growth potential.
What would affect this ETF?The TBG Dividend Focus ETF could benefit from stable economic conditions and low interest rates, which often support dividend-paying companies and sectors like Health Care, Consumer Defensive, and Real Estate. However, rising interest rates or economic downturns might negatively impact dividend yields and sectors such as Financials and Real Estate. Additionally, regulatory changes in the U.S., where the ETF is focused, could influence the performance of top holdings like Simon Property and Chevron.
TBG Top 10 Holdings
The TBG Dividend Focus ETF leans heavily into dividend-rich sectors like Health Care and Energy, with notable contributions from steady performers like Johnson & Johnson and Gilead Sciences, whose strong financials and strategic growth are driving the fund forward. Cisco Systems is also rising, buoyed by its focus on AI and shareholder returns. On the flip side, Chevron and PepsiCo are lagging, with recent declines tempering their impact. With a U.S.-centric portfolio and a diverse sector mix, the fund balances stability and income, though a few names are holding back its momentum.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Simon Property | 5.03% | $9.75M | $59.63B | 1.42% | 74 Outperform | |
| Merck & Company | 4.72% | $9.15M | $249.20B | -0.75% | 78 Outperform | |
| ― | 4.59% | $8.89M | ― | ― | ― | |
| Cisco Systems | 4.24% | $8.22M | $301.23B | 29.79% | 77 Outperform | |
| Verizon | 4.11% | $7.96M | $169.54B | -8.57% | 72 Outperform | |
| Johnson & Johnson | 3.95% | $7.65M | $496.44B | 32.27% | 78 Outperform | |
| Chevron | 3.88% | $7.51M | $301.52B | -6.62% | 74 Outperform | |
| Gilead Sciences | 3.68% | $7.13M | $155.42B | 38.44% | 77 Outperform | |
| PepsiCo | 3.51% | $6.81M | $198.95B | -10.76% | 78 Outperform | |
| Brookfield Infrastructure | 3.19% | $6.18M | $5.79B | -1.20% | 56 Neutral |
TBG Technical Analysis
Positive
―
Price Trends
32.96
Positive
32.93
Positive
32.21
Positive
Market Momentum
0.06
Negative
54.26
Neutral
54.89
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TBG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.85, equal to the 50-day MA of 32.96, and equal to the 200-day MA of 32.21, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 54.26 is Neutral, neither overbought nor oversold. The STOCH value of 54.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TBG.
TBG Peer Comparison
Comparison Results
Performance Comparison
TBG
TBG Dividend Focus ETF
33.14
0.16
0.49%
FDV
Federated Hermes U.S. Strategic Dividend ETF
―
―
―
ELCV
Eventide High Dividend ETF
―
―
―
HIDV
AB US High Dividend ETF
―
―
―
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents